Arbor Trust Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Arbor Trust Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,489	Closed	-$202K	–	93
2023 Q3	$202K	Buy	3,489 +25	+0.7%	+$1.53K	0.13%	87
2023 Q2	$222K	Sell	3,464 -116	-3%	-$7.78K	0.14%	89
2023 Q1	$248K	Hold	3,580	–	–	0.16%	83
2022 Q4	$258K	Hold	3,580	–	–	0.18%	83
2022 Q3	$254K	Hold	3,580	–	–	0.19%	80
2022 Q2	$278K	Hold	3,580	–	–	0.19%	82
2022 Q1	$263K	Sell	3,580 -25	-0.7%	-$1.68K	0.16%	88
2021 Q4	$225K	Hold	3,605	–	–	0.13%	98
2021 Q3	$215K	Hold	3,605	–	–	0.13%	97
2021 Q2	$241K	Hold	3,605	–	–	0.15%	91
2021 Q1	$228K	Sell	3,605 -25	-0.7%	-$1.55K	0.15%	89
2020 Q4	$227K	Hold	3,630	–	–	0.16%	86
2020 Q3	$219K	Hold	3,630	–	–	0.19%	74
2020 Q2	$213K	Hold	3,630	–	–	0.19%	81
2020 Q1	$202K	Sell	3,630 -50	-1%	-$3.06K	0.21%	80
2019 Q4	$236K	Buy	+3,680	New	+$211K	0.2%	77

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Arbor Trust Wealth Advisors's BMY Position: Q4 2023 in Review

Arbor Trust Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,489 shares — an estimated $202K sold.

Arbor Trust Wealth Advisors first reported a position in BMY in Q4 2019 and held it in 16 quarters. The position peaked at $278K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Arbor Trust Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Arbor Trust Wealth Advisors sold 3,489 Bristol-Myers Squibb shares in Q4 2023, an estimated $202K.
Arbor Trust Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 16 quarters.
Arbor Trust Wealth Advisors's Bristol-Myers Squibb position peaked at $278K in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Arbor Trust Wealth Advisors's 13F filing for Q4 2023, filed 30 Jan 2024.